Perindopril Erbumine
Drug Details
- Generic Name
- Perindopril Erbumine
- Brand Names
- Perindopril Erbumine
- Application Number
- ANDA079070
- Sponsor
- Alivus Life Sciences Limited
- NDC Codes
- 9
- Dosage Forms
- POWDER, TABLET
- Routes
- ORAL
- Active Ingredients
- PERINDOPRIL ERBUMINE
Indications and Usage
1 INDICATIONS AND USAGE Perindopril erbumine tablets are indicated for the treatment of patients with essential hypertension. (1.1) Perindopril erbumine tablets are indicated for treatment of patients with stable coronary artery disease to reduce the risk of cardiovascular mortality or nonfatal myocardial infarction. (1.2) 1.1 Hypertension Perindopril erbumine tablets are indicated for the treatment of patients with essential hypertension. Perindopril erbumine tablets may be used alone or given with other classes of antihypertensives, especially thiazide diuretics. 1.2 Stable Coronary Artery Disease Perindopril erbumine tablets are indicated for treatment of patients with stable coronary artery disease to reduce the risk of cardiovascular mortality or nonfatal myocardial infarction. Perindopril erbumine tablets can be used with conventional treatment for management of coronary artery disease, such as antiplatelet, antihypertensive or lipid-lowering therapy.